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Abstract
To gain insight into Epstein–Barr virus (EBV) glycoprotein B (gB), recombinant, secreted variants were generated. The role of putative
transmembrane regions, the proteolytic processing and the oligomerization state of the gB variants were investigated. Constructs containing 2 of 3
C-terminal hydrophobic regions were secreted, indicating that these do not act as transmembrane anchors. The efficiency of cleavage of the gB
furin site was found to depend on the nature of C-terminus. All of the gB constructs formed rosette structures reminiscent of the postfusion
aggregates formed by other viral fusion proteins. However, substitution of putative fusion loop residues, WY112–113 and WLIY193–196, with less
hydrophobic amino acids from HSV-1 gB, produced trimeric protein and abrogated the ability of the EBV gB ectodomains to form rosettes. These
data demonstrate biochemical features of EBV gB that are characteristic of other class I and class II viral fusion proteins, but not of HSV-1 gB.
© 2007 Elsevier Inc. All rights reserved.Keywords: Herpesvirus; Epstein–Barr virus; Glycoprotein B; Entry; Fusion; Rosette; Fusion peptide; Fusion loopHerpesviruses are enveloped viruses that contain a large
double stranded DNA genome, and the family of viruses
contains more than 120 members. The eight herpesviruses that
infect humans are classified into α, β and γ subfamilies based
on their evolutionary distance and properties of their life cycle.
The γ-herpesviruses, Epstein–Barr virus (EBV) and human
herpesvirus 8 (HHV-8) are unique for their involvement in the
development of cancers. EBV is one of the most common
human viruses, and more than 90% of the population is
estimated to be carrying the virus. EBV is spread through
saliva, and after initially infecting the epithelium of the oral
pharynx, EBV establishes life-long latency in B cells (Rick-
inson and Kieff, 2001). Consistent with the target tissues, EBV
infections have been associated with malignancies of lymphoid
cells such as Burkitt's lymphoma, Hodgkin's lymphoma, adult
T cell leukemia and B cell lymphoproliferative disease (Cohen,
2000; Speck et al., 2000), and with the development of gastric⁎ Corresponding author. Fax: +1 847 467 6489.
E-mail address: tjardetz@stanford.edu (T.S. Jardetzky).
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doi:10.1016/j.virol.2007.06.031and nasopharingeal carcinoma and oral hairy leukoplakia
(Cohen, 2000; Osato and Imai, 1996; Rickinson and Kieff,
2001). As with all herpesviruses, EBV enters cells by fusion of
the viral and host-cell membranes. However, the mechanism
underlying the merging of these membranes is unclear.
Understanding the molecular basis of the fusion process is of
critical importance for the design and development of thera-
peutic agents that would aid in the treatment of EBV-related
illnesses.
EBV binds to B cells through an interaction of viral
glycoprotein 350 and cell surface-expressed CD21 (Nemerow
et al., 1985). Epithelial cells, which do not express CD21, are
still prone to EBV infection (Janz et al., 2000), and in this case
glycoprotein H (gH) is proposed to participate in the attachment
(Molesworth et al., 2000). Another route for infection of
epithelial cells involves a coordinated infection of B cells and
epithelial cells, and occurs though a transfer of EBV virions
from resting B cells to epithelial cells. In the presence of B cells,
EBV infects epithelial cells 103–104 more efficiently compared
to the cell-free virus (Shannon-Lowe et al., 2006).
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another glycoprotein of the EBV envelope, gp42, binds to the
major histocompatibility complex type II (MHCII) molecule, a
protein expressed on the surface of B cells that presents antigens
to T cells. The gp42–MHCII interaction serves as a trigger for
fusion and it is essential for EBV infection of B cells (Haan et
al., 2000; Li et al., 1997). Epithelial cells do not express MHCII,
and gp42 is thought to interfere with their infection (Borza and
Hutt-Fletcher, 2002; Li et al., 1995). Recombinant virus lacking
gp42 binds to B cells but does not infect them, although this can
be overcome by the addition of soluble gp42-Fc protein (Wang
and Hutt-Fletcher, 1998; Wang et al., 1998). Similarly, an
antibody directed against gp42 inhibits infection of B cells but
not epithelial cells (Wang and Hutt-Fletcher, 1998). Similar
observations on the ability of soluble gp42 to rescue cell:cell
fusion with B cells in a virus-free assay have been made
(Kirschner et al., 2006). The nature of the fusion trigger in the
epithelial cell infection is not known, but the addition of soluble
gp42 in a cell–cell fusion assay is inhibitory at nanomolar
concentrations (Kirschner et al., 2006).
Although EBV uses different sets of receptors to bind to and
trigger fusion in B and epithelial cells, the core fusion machinery
is the same in both cases, and consists of glycoprotein B (gB) and
a noncovalently associated complex of glycoproteins H and L
(gH/gL). This core fusion machinery is conserved throughout
the herpesvirus family.
Based on their structural features, the majority of the viral
proteins that mediate fusion can be assigned as class I or
class II fusion proteins. Class I proteins, such as influenza virus
hemagglutinin, F protein of paramyxoviruses and Env proteins
of retroviruses, are mostly α-helical in their fusogenic subunits
(Harrison, 2005). They form trimers and do not change
oligomerization state during a refolding event that leads to
fusion. The principal structural feature of class I proteins is the
formation of a prominent trimeric α-helical coiled coil in the
postfusion conformation. In contrast, class II fusion proteins,
found in flaviviruses and alphaviruses, are predominantly
composed of β-sheets. They form dimers on the surface of
virions, but undergo a structural rearrangement to form stable
postfusion trimers (Kielian and Rey, 2006).
In contrast to class I and class II fusion proteins where there
is a single fusogenic protein, it is not clear whether gB, the gH/
gL complex, or all three proteins play this role in herpesviruses.
For herpes simplex virus-1 (HSV-1) gB, gH/gL and gD are
required for fusion in a cell:cell based assay (Turner et al.,
1998). On the other hand, the gH/gL complex from Varicella-
Zoster virus and HHV-8 on its own induces low levels of fusion
in a similar assay (Duus et al., 1995; Pertel, 2002). A mutant of
HHV-8 gB, which exhibits an enhanced surface expression, also
has some fusion potential, although less than found when
HHV-8 gH/gL are expressed together (Pertel, 2002). Most
strikingly, expression of a truncated variant of EBV gB that
lacks the last 46 residues of the gB cytoplasmic tail can induce
fusion with epithelial cells (McShane and Longnecker, 2004). A
link between the amount of gB in the EBV envelope and the
ability of the virus to infect cells has also been observed. EBV
strains that have more envelope-bound gB exhibit an increasedability to infect cells that are normally refractory to EBV
infections (Neuhierl et al., 2002). The results of these functional
studies suggest strongly that gB has inherent fusogenic
properties.
A recently determined atomic structure of the HSV-1 gB
ectodomain revealed an unanticipated and notable structural
homology between gB and the vesicular stomatitis virus (VSV)
fusogenic G protein, despite a lack of sequence similarity
between the two proteins (Heldwein et al., 2006; Roche et al.,
2006). Both proteins form trimers and contain a prominent
alpha-helical coiled-coil core that relates them to class I fusion
proteins, but they also contain extended β-hairpins homologous
to the fusion peptides of class II fusion proteins. The overall fold
of the proteins is unique and it has been proposed that gB and G
protein should be classified into a new, third class of fusion
proteins (Steven and Spear, 2006).
G protein is the sole fusogenic protein of VSV, and as for
class I and II fusion proteins, it undergoes a major conforma-
tional change as a part of the fusion mechanism (Roche et al.,
2007). The G protein does not fold into a metastable state and
this distinguishes VSV G from class I and II fusion proteins,
which undergo an irreversible protein refolding event. In
contrast, the VSV G conformational change induced by its
exposure to low pH in endosomes is reversible (Gaudin, 2000).
Whether structural homology between gB and G protein
translates into functional homology remains to be determined.
We provide evidence that recombinant EBV gB ectodomains
have features that biochemically relate gB to other fusogenic
proteins and we identified residues that form putative fusion
loops in EBV gB, providing insight into the distinct fusogenic
properties of the HSV and EBV gB proteins.
Results and discussion
Rationale for construction of recombinant gB ectodomain
variants
Glycoprotein B is highly conserved in the herpesvirus
family, and for EBV it was identified as a homologue of the
HSV-1 gB protein (Gong et al., 1987) with which it shares 29%
identity and 43% similarity at the protein sequence level. HSV-1
gB contains three hydrophobic segments close to its C-terminus,
and only the C-terminal proximal segment is required for
membrane anchoring (Rasile et al., 1993). For EBV gB, there are
three analogous putative membrane spanning regions, corre-
sponding to residues 686–705, 710–730 and 733–753 of the
unprocessed protein (Gong et al., 1987; Pellett et al., 1985)
(Fig. 1A). Our analysis indicates that only the last two
hydrophobic segments are hydrophobic enough to transverse
the lipid bilayer (Krogh et al., 2001; von Heijne, 1992), and
we suspected that similar to HSV-1 gB, the last and most
hydrophobic segment of EBV gB (residues 733–753) serves
as a single transmembrane anchor domain. However, since the
membrane boundaries and topology of EBV gB were not
clear, gB constructs of different lengths were created.
A short ectodomain construct (EctoS, residues 23–683) was
made lacking all three hydrophobic segments, and it was
Fig. 1. Schematic representation of (A) full-length gB: the ectodomain (residues 23 to 683) is shown as filled with dots, the C-terminal intracellular domain (CTD) is
represented by the clear box. Mature protein is produced after cleavage of the 22-residue long signal peptide at the N-terminus (horizontal lines). The three membrane-
proximal regions, residues 686–705, 710–730 and 733–753, are between the ectodomain and the CTD; (B) the short ectodomain variant (EctoS) comprises
residues 23–683 of gB and lacks all three membrane-proximal regions; (C) the long ectodomain variant (EctoL), residues 23–733 of gB, includes the first two
membrane-proximal regions and a GCN4 trimerization domain (black box); (D) EctoL/EK is the same as the variant as described in panel C, but contains an
enterokinase recognition site DDDDK instead of the wild-type furin cleavage site RRRRR (residues 428–432).
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The C-terminus of this ectodomain is identical to the
corresponding position where the crystallized HSV-1 gB
ectodomain was truncated (Heldwein et al., 2006).
Since EBV gB forms oligomers in vivo (Claesson-Welsh and
Spear, 1986; Grunewald et al., 2003) and a recent X-ray
structure of HSV-1 gB revealed a gB trimer (Heldwein et al.,
2006), the long ectodomain (EctoL) variant was also extended
to include the first two hydrophobic regions and a GCN4
trimerization domain, the latter replacing the putative trans-
membrane segment (Fig. 1C). The EctoL construct also
permitted the evaluation of the importance of the first two
hydrophobic regions for the protein structure and in membrane
anchoring. In fusion proteins such as tick-borne encephalitis
(TBE) virus E protein and VSV G protein, analogous
hydrophobic, membrane-proximal regions play an important
role in the fusion mechanism and/or stabilization of protein
structure as a whole (Jeetendra et al., 2003; Jeetendra et al.,
2002; Stiasny et al., 2005). The GCN4 trimerization sequence
forms a three helix bundle (Harbury et al., 1994; Harbury et al.,
1993) and it was used previously as a soluble substitute for
hydrophobic, insoluble transmembrane helices of trimeric
fusion viral proteins such as the F protein of the parainfluenza
virus 5 and HIV env (Pancera et al., 2005; Yin et al., 2006).
Addition of the GCN4 trimerization domain to the C terminus
of the paramyxovirus F protein allowed the crystallization of the
prefusion conformation of the protein. Thus it seemed possible
that the longer gB constructs containing the trimerization
domain might also produce a soluble version of the membrane-
anchored oligomeric gB, in a conformation more closely related
to its functional state in vivo.
Proteolytic processing is essential for the fusion mechanism
of the class I and II fusion proteins (Harrison, 2005; Kielian and
Rey, 2006). Cleavage at a conserved furin site renders class Ifusion proteins in an activated fusion-competent state. In class II
proteins, cleavage of an accompanying protein causes a
conformational change that alters the oligomerization state of
the fusion protein and consequently allows membrane fusion.
EBV gB contains a furin recognition sequence RRRRR
(residues 428–432) that is poorly conserved among herpes-
viruses. To investigate the effect of cleavage, if any, on
properties and potentially folding of the recombinant protein, a
long variant EctoL/EK was made that contains an enterokinase
(EK) recognition sequence DDDDK in place of the furin
cleavage site (Fig. 1D). A detailed description of generation of
the DNA constructs is given in Materials and methods.
Expression and purification of recombinant gB ectodomains
Recombinant gB ectodomains were expressed in High
Five insect cells using baculovirus. DNAs encoding the gB
ectodomains were cloned into expression vector pBACgus-3
after the gp64 signal sequence that drives protein secretion.
Supernatants were collected at different time points post-
infection, and the optimal harvesting time for both the EctoS
and EctoL variants was found to be between 48 and 56 h post-
infection (data not shown). Significant losses of gB in the
supernatants were observed at later times, most likely due to
proteolysis caused by the release of proteases during cell death.
All three gB variants were secreted efficiently into the
supernatants of infected cells, with expression levels of at least
100 to 400 μg per liter of medium. Attempts to purify the EctoS
variant, which contained a histidine tag at the C-terminus, using
immobilized metal ion affinity chromatography were unsuc-
cessful, partly because of unidentified competing substances in
the media, and possibly due to inaccessibility of the histidine
tag. The protein was successfully purified from the supernatants
using an immobilized anti-gB monoclonal antibody (CL55)
Fig. 2. Western blot of fractions collected during purification of the EctoS gB
variant on the CL55 antibody column. The primary antibody used for blotting
recognizes the histidine tag. The samples were run under non-reducing
conditions. Elution was done with 0.2 M glycine pH 2.5 as described in
Materials and methods.
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(Fig. 2), and the immunoaffinity purified gB was at least 95%
pure as estimated by SDS-PAGE (Fig. 3A). Yields of the pure
protein were 50 to 200 μg per liter of supernatant. The same
protocol was used for purification of all of the gB variants
described in this study. Fig. 2 is representative of the results
obtained for the rest of the gB variants as well.
Efficient secretion of EctoL variants, which contain the first
two hydrophobic regions, demonstrated that these two regions
alone were not sufficient to anchor the gB in the membrane,
indicating that the third hydrophobic region is the domain that
spans the membrane. These data suggest strongly that the EBV
gB transmembrane topology is similar to that of HSV-1 gB.Fig. 3. Coomassie brilliant blue stained SDS-PAGE gels: (A) EctoS and EctoL varia
Upon addition of DTT, a significant fraction of the EctoL, but not of the EctoS, varian
∼70 kDa and ∼40 kDa EctoS fragments under reducing conditions indicates proteo
variant migrates as a single chain regardless of the presence of a reducing agent indicat
(EK) cleaves the protein into two fragments.Proteolytic processing of recombinant gB ectodomains
EBV gB protein contains a furin recognition sequence,
RRRRR (residues 428 to 432), which is analogous to furin
recognition sites found in some class I fusion proteins (reviewed
in (Dutch et al., 2000)). However, in EBV gB, the furin cleavage
site is not located near to a hydrophobic peptide sequence, as
found for class I fusion proteins. In EBV virions, the majority of
gB is found in a cleaved form that contains a 78 kDa N-terminal
fragment and a 58 kDa C-terminal fragment, and a small
fraction of the total gB is uncleaved (Johannsen et al., 2004).
The observed molecular masses correspond well to the sizes of
fragments expected to be produced by cleavage at the furin site.
To determine if the recombinant gB undergoes similar
proteolytic processing in High Five cells, purified ectodomains
were analyzed on SDS-PAGE gel in the absence and presence of
a reducing agent (Fig. 3).
Similar to the gB protein isolated from EBV virions, two
fragments migrating just below 70 kDa and 40 kDa markers
were detected for the recombinant EctoS variant in the presence
of a reducing agent (Fig. 3A). This is in agreement with the in
vivo findings described above (the C-terminal fragment is
expected to be smaller in the recombinant material, since the
ectodomain construct lacks the intracellular gB domain). The
faster migrating 40 kDa fragment was recognized by an anti-
histidine antibody in an immunoblot (data not shown),
demonstrating the presence of the C-terminal histidine tag.
This band was cut out, and N-terminal sequencing revealed
DAGXAT a sequence that matches the predicted residues
DAGNAT that follow the furin recognition sequence (thents migrate as single polypeptide chains in the absence of reducing agent (left).
t remains intact and is labeled with a star (right panel of Fig. 3A). The presence of
lytic cleavage of the EctoS variant (right panel of Fig. 3A). (B) The EctoL/EK
ing the lack of cleavage (left and middle lanes). Extraneously added enterokinase
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was glycosylated). These data indicate that the recombinant EctoS
variant was cleaved at the furin site into two fragments linked
together by disulfide bonds, and the data suggest strongly that
recombinant gB material is processed in insect cells similar to the
gB protein incorporated into EBV virions.
Unlike the EctoS variant, that was almost entirely cleaved in
High Five cells, a significant portion of the EctoL variant was
not processed and in the presence of a reducing agent migrated
as a single polypeptide chain of observed molecular mass of
∼120 kDa (Fig. 3A). The presence of the extended C-terminus
of the EctoL variant, and potentially the C-terminal trimeriza-
tion domain, appears to influence the accessibility of the furin
cleavage site. In EBV gB, the furin site is located in a region
rich in serine and proline residues, which is longer in EBV gB
than in gB of other herpesviruses. This region is not resolved in
the HSV-1 gB crystal structure due to its high flexibility, but it
may be an extended chain sufficiently long to interact with
the ectodomain C-terminus. Another possibility is that the
C-terminal extension in the EctoL variant alters indirectly the
more global conformation of the ectodomain, which would
result in concealing the furin site. In the class II fusion protein E
of TBE virus, differences in the thermal stability and fold of the
full-length and a truncated version of the protein were attributed
to the presence of an extended C-terminus in the former (Stiasny
et al., 2005). In addition, a GCN4 appended variant of the class I
fusion protein F folds and stays locked in the metastable
prefusion state, unlike a shorter variant that adopts a more stable
postfusion conformation (Yin et al., 2006). However, how these
observations on other fusion proteins may relate to EBV gB
remains to be determined.
The EctoL/EK variant, which lacks the furin recognition
sequence, was not cleaved in High Five cells as expected and it
migrated as a single chain regardless of the presence of the
reducing agent (Fig. 3B). Cleavage of gB was observed when
enterokinase was added exogenously.
The furin site found in EBV gB is not highly conserved
among herpesviruses, but is found in human herpesvirus 8,Fig. 4. (A) Chromatogram obtained for immunoaffinity purified EctoS variant using a P
indicating the presence of oligomers of molecular mass larger than 1300 kDa. (B) M
Irregular rosettes, reminiscent of rosettes formed by class I and class II fusion proteins,cytomegalovirus (CMV), bovine herpes virus 1 (BHV-1) and
pseudorabies virus (PRV). The furin site is not present in HSV-1
and HSV-2 gB, although HSV-2 gB is processed at a
neighboring non-furin site (Norais et al., 1996). The physiolo-
gical importance of proteolytic processing for gB function in
human viruses is not clear. Abrogating the cleavage in BHV-1,
CMV gB and PRV decreases cell-to-cell virus spread, but
cleavage is dispensable for viral growth (Blewett and Misra,
1991; Okazaki, 2007; Strive et al., 2002).
Oligomerization state of recombinant gB ectodomains
Several reports have indicated that herpesvirus gB may form
dimers in vivo (Claesson-Welsh and Spear, 1986; Grunewald
et al., 2003), but it was found that the recombinant HSV-1 gB
ectodomains used for crystallization formed trimers (Held-
wein et al., 2006). The oligomerization state of the
recombinant EBV gB variants was evaluated using Superdex
200 (S200) size exclusion chromatography. The chromatogram
shown in Fig. 4Awas obtained for EctoS, and is representative
of the results obtained for the EctoL and EctoL/EK variants.
Dimers (220 kDa) and trimers (330 kDa) of gB would be
expected to elute from the column later than 8.58 ml and before
9.92 ml, which are the elution volumes corresponding to the
443 kDa and 200 kDa protein standards. The gB oligomers,
however, eluted in the column void volume peak, fractions 10
and 11 (Fig. 4A), indicating that they were larger than the S200
size exclusion limit of 1300 kDa. An attempt to separate the gB
variants on a TSK G4000SW size exclusion matrix, a matrix
more suitable for purification of hydrophobic proteins, gave the
same results (data not shown).
To obtain macroscopic insight into the nature of the purified
ectodomains, protein samples from the void volume peak were
stained with 2% phosphotungstate and were examined by
transmission electron microscopy. As shown in Fig. 4B,
numerous rosettes, containing varying numbers of 15–20 nm
long protruding arms, were detected. The rosette structures were
observed for the long gB variants as well. The length of theharmacia S200 gel filtration column. gB elutes in the void volume of the column,
aterial from the void volume fractions was visualized by electron microscopy.
were detected. Each arm is 15–20 nm long and represents most likely a gB trimer.
Fig. 5. Sucrose gradient centrifugation of (A) supernatant containing EctoS gB
variant, and (B) EctoS gB purified using immunoaffinity chromatography. The
sucrose gradient distribution of the recombinant gB from supernatant does not
differ from the distribution profile observed for the purified variant. These data
suggest strongly that the oligomerization state of the recombinant gB does not
change during immunoaffinity purification.
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HSV-1 gB ectodomain X-ray structure (Heldwein et al., 2006),
and with 20 nm long rods proposed to be the gB spikes in the
HSV-1 virions (Grunewald et al., 2003; Stannard et al., 1987).
The large molecular mass of the rosettes (mass inferred from
the size exclusion chromatography data) implies that each of
the arms of the rosettes must contain at least a gB dimer or
trimer, rather than a gB monomer. Moreover, the shape of the
gB rosettes carries a striking resemblance to the rosettes
formed by class I fusion proteins, such as the F protein of
human respiratory syncytial virus (Calder et al., 2000;
Gonzalez-Reyes et al., 2001) and simian virus 5 (Connolly et
al., 2006), influenza virus hemagglutinin (Ruigrok et al.,
1988), and class II fusion protein E1 of Semliki Forest virus
(Gibbons et al., 2004). In all cases, the fusion proteins had
undergone a conformational change and were in their
postfusion conformations with the exposed hydrophobic fusion
peptides interacting with each other and causing the aggrega-
tion. Similar to these other fusion proteins, the secreted EBV
gB forms rosettes through interactions at one end of a long,Fig. 6. (A) Chromatogram obtained for immunoaffinity purified EctoL variant using
sample and running buffer. gB elutes in the 8.67 ml peak and is most likely in trimeric
fractions corresponding to the gB trimer peak. Rods are 15–20 nm long, although
correspond to two interacting gB trimer rods.rod-like structure. The exposure of gB to low pH during
elution from the antibody affinity column, and proteolytic
processing at the furin site were ruled out as causes of the gB
rosettes formation. Recombinant proteins that were eluted with
a near-neutral pH using Gentle Elution buffer (Pierce), and the
EctoL/EK variant, which did not undergo proteolytic proces-
sing, also exhibited the same size exclusion profile as shown in
Fig. 4A.
In addition, to confirm that the recombinant EctoS gB formed
oligomers prior to purification, concentrated supernatant and
immunoaffinity purified gB were subjected to centrifugation in
10–60% sucrose. Gradients were fractionated and each fraction
was analyzed for the presence of gB by SDS-PAGE andWestern
blotting. gB from supernatant (Fig. 5A) and purified gB (Fig.
5B) exhibit the same distribution through the sucrose gradient,
indicative of the presence of the oligomers in both the
supernatant and purified protein. These data further supported
our interpretation that EBV gB spontaneously forms rosettes
when secreted.
Effect of detergents on oligomerization state of recombinant gB
ectodomains
To determine if the formation of gB rosettes was driven by
hydrophobic interactions, as shown for class I and II fusion
proteins, the gB variants were subjected to size exclusion
chromatography in the presence of high concentrations of a
strong detergent, deoxycholate. As shown in Fig. 6A, a peak
containing EctoL gB was detected at 8.67 ml. Samples collected
from the peak fractions 14–20, or immunoaffinity purified gB
treated with deoxycholate, were used for examination by
electron microscopy to investigate further the effects of
detergent on rosette formation. Negatively stained samples
revealed the presence of multiple individual rod structures,
likely to be trimers of gB, rather than rosettes (Fig. 6B). The
length of the majority of rods was in the range of 15–20 nm
similar to what has been observed for the HSV-1 gB trimersa Pharmacia S200 gel filtration column in the presence of deoxycholate in the
form. (B) gB rods were visualized by EM in the EctoL gB sample obtained from
some longer ∼30 nm rods are present (marked with asterisk sign) and may
Fig. 7. Putative fusion loops and their role in rosette formation. X-ray structure of HSV-1 gB ectodomain: (A) for clarity only HSV-1 gB monomer is shown, (B) gB
HSV-1 trimer is shown. Residues forming putative fusion loops in HSV-1 gB HR177–178 and RVEA258–261 are represented, respectively, as blue and red sticks. (C)
Hypothetical model of rosettes observed for EBV gB created by docking HSV-1 gB trimers to interact through the putative fusion loops (which in EBV gB contain
hydrophobic residues WY112–113 and WLIW193–196). EBV gB rosettes shown in Fig. 4 are irregular indicating that the geometric constrains allow association of a
variable number of EBV gB trimers. However, the model shown here is descriptive and was not created to model rosettes in any detailed manner. Images were
generated using PyMOL (8). The PDB accession number for HSV-1 gB is 2gum (23).
108 M. Backovic et al. / Virology 368 (2007) 102–113(Heldwein et al., 2006) and for the arms forming the EBV gB
rosettes. Some longer rods of ∼30 nm have been observed as
well, most likely representing two rods, each made of a gB
trimer, held together. The results shown in Fig. 6 are
representative of the results obtained for EctoS and EctoL/EK
variants purified in the presence of deoxycholate. Rods were
also observed when deoxycholate was added to the gB variants
purified on CL55 matrix.
The ability of deoxycholate to disrupt the gB aggregates into
smaller species supports the idea that the gB molecules are held
together by hydrophobic interactions. If a conformational
change is indeed a part of the fusion mechanism mediated by
gB, rosette formation due to hydrophobic interactions would
indicate that the recombinant ectodomains described here could
be in a postfusion state.Table 1
Loop 1
residues
Hydrophobicity Loop
residu
KD CCS
HSV-1 GHRY176–179 −2.35 −3.42 RVEA
HSV-2 GHRY171–174 −2.35 −3.42 RVEA
CMV YIYT155–158 0.3 2.47 GSTW
HHV-6 DVGV101–104 −0.94 −2.25 GPLW
EBV GWYA111–114 −0.2 2.17 WLIW
HHV-8 GLTE127–130 −0.19 −1.2 WFPG
Hydrophobicity of residues forming putative fusion loops in gB is shown for six he
human herpes virus 6 (HHV-6), Epstein–Barr virus (EBV) and human herpes
hydrophobicity of each loop, and the loops together, is expressed per residue. KD and
and combined consensus scale (Tossi et al., 2002). The larger number corresponds to
(from top to bottom): P10211, P06763, P06473, P36319, P88906 and P03188.Formation of EBV gB rosettes is mediated by residues
WY112–113 and WLIV193–196
The protein sequences of HSV-1 and EBV ectodomains
share 29% identity and 43% similarity. The crystallized
trimeric HSV-1 gB ectodomain (Heldwein et al., 2006) was
truncated at the same position as the EctoS variant, but the
HSV-1 gB recombinant protein has not been reported to
aggregate. The formation of the EBV gB rosettes was thus
unexpected, and demonstrated that despite the high similarity,
the EBV gB protein behaves differently than the HSV-1
counterpart. A truncated cytoplasmic domain variant of EBV
gB, but not of HSV-1, induces fusion in a gH/gL-independent
manner (McShane and Longnecker, 2004), and demonstrates
that the EBV gB protein has greater inherent fusogenic2
es
Hydrophobicity Loop 1+2 average
KD CCS KD CCS
F258–262 −0.57 −1.06 −1.36 −2.11
F253–257 −0.57 −1.06 −1.36 −2.11
L237–241 0.19 1.77 0.24 2.08
Y184–188 −0.4 3.85 −0.64 1.14
T193–197 1.15 6.8 0.55 4.74
I209–213 0.55 5.16 0.22 2.33
rpesviruses: herpes simplex 1 and 2 (HSV-1, HSV-2), cytomegalovirus (CMV),
virus 8 (HHV-8). Numbering corresponds to unprocessed proteins. Average
CCD stand for hydrophobicities calculated based on Kyte and Doolittle (1982)
higher hydrophobicity. Swiss–Prot entry numbers for the sequences shown are
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(Figs. 7A and B), structurally analogous to the well-defined
bipartite fusion peptide of VSV G protein, were proposed to
form a putative fusion peptide in HSV-1 gB (Hannah et al., 2007;
Heldwein et al., 2006). The hydrophobicities of each putative
fusion loop and their average values were calculated for gB
from six human herpesviruses using two hydrophobicity scales
(Table 1). Interestingly, the residues present in HSV-1 gB are
charged and not particularly hydrophobic (GHRY, RVEAF). In
contrast, the analogous putative fusion loop regions in EBV gB
are very hydrophobic (GWYA, WLIWT), consistent with their
potential role in direct contact with membranes and fusion. We
speculated that the higher hydrophobicity underlies the ability
of EBV gB to form rosettes (a hypothetical model of rosettes is
shown in Fig. 7C) and may confer its enhanced capacity to
induce fusion in the absence of gH/gL. This would also suggest
that, in herpesviruses containing gB with less hydrophobic
loops, any differences in the energetic requirements for mem-
brane fusion would have to be provided by other regions of gB
and/or by gH/gL.
To determine if the rosette formation was driven by the
hydrophobic residues in the EBV gB putative fusion loops (FL),
the EctoS/FL protein variant was created that had the wild type
residues WY112–113 and WLIW193–196 substituted for HR and
RVEA, the analogous residues from HSV-1 gB. The EctoS/FL
variant was expressed and purified as described for the EctoS
and EctoL variants. As shown in Fig. 8A, the EctoS/FL variant
was detected in fractions 16–20 and eluted from an S200
column at 8.86 ml, close to the elution volume observed for the
putative gB trimer peak obtained in the presence of
deoxycholate (Fig. 6A). Based on the calibration of the S200
column with protein standards, the 8.86 ml elution volume was
calculated to correspond to a species of molecular mass of
∼380 kDa. These data indicated that the EctoS/FL variant
formed trimers similar to what was observed for the HSV-1 gB
ectodomains (Heldwein et al., 2006). Electron microscopy
revealed the presence of ∼15 nm long gB rods, and no rosette
structures were observed (Fig. 8B). The absence of rosettes inFig. 8. Elution profile of EctoS/FL gB variant using a Pharmacia S200 gel filtration co
is detected in fractions 17–20 by SDS-PAGE and Western blotting using anti-gB anti
observed by electron microscopy. Rosette structures were not observed in EctoS/FLEctoS/FL protein preparations, which were obtained following
the identical procedure as described for the variants that do
aggregate, confirmed that the rosette formation does not occur
as a consequence of isolation and purification methods
involved, but is solely a function of the presence of the
hydrophobic residues in the EBV gB fusion loops.
Substitution of EBV gB WY112–113 and WLIW193–196
residues for corresponding residues from HSV-1 gB (HR and
RVEA) resulted in a gB variant that is not capable of mediating
fusion with epithelial or B cells, indicating the critical
importance of the hydrophobic and bulky residues for EBV
gB function (Backovic et al., 2007). Data shown here
demonstrate that the same residues confer the ability of EBV
gB to form rosettes, and suggest strongly that WY112–113 and
WLIW193–196 form the internal fusion peptide in EBV gB.
Final remarks
While, the VSV G protein and HSV-1 gB show structural
features of both class I and class II fusion proteins, biochemical
evidence that would relate gB to class I and class II fusion
proteins has been lacking. In electron micrographs, the secreted
EBV gB oligomers were found to carry a striking resemblance
to the rosettes formed by class I and II fusion proteins in their
postfusion conformations (Calder et al., 2000; Connolly et al.,
2006; Gibbons et al., 2004; Gonzalez-Reyes et al., 2001; Ruigrok
et al., 1988). We propose that WY112–113 and WLIW193–196
form the internal fusion peptides of EBV gB, and that the higher
hydrophobicity of EBV gB loops may confer its enhanced
fusogenicity, i.e. ability to cause fusion in a gH/gL-independent
manner, as compared to other herpesvirus gB proteins.
The nature of the fusion peptides and the possibility of a gB
conformational change that could parallel that observed for
VSV G, need to be investigated further. Based on the structural
similarities between HSV-1 gB and VSV G, as well as the
functional observations made here with EBV gB, it is likely that
the secreted HSV-1 and EBV gB proteins have folded to a
postfusion conformation, with fusion loops co-localized to onelumn. (A) gB elutes in the 8.86 ml peak which corresponds to a gB trimer, and gB
body. (B) Numerous individual rods, 15 nm long, representing gB trimers, were
protein preparations.
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protein, fusion loops are separated on extended legs of a tripod-
like structure and the overall length of the protein is shortened
(Roche et al., 2007). It is not clear whether herpesvirus gB
proteins form an analogous prefusion conformation and there are
significant differences in the HSV-1 and VSV G structures that
complicate direct modeling of this putative form. Nonetheless, it
is likely that full-length membrane-bound gB adopts a different
conformation than the truncated, soluble gB. The truncation of
the EBV gB C-terminal cytoplasmic region was shown to
promote gB to adopt a more fusogenic form (McShane and
Longnecker, 2004), which could also lead to conversion to a
postfusion form in the absence of membrane anchoring.
Truncation of the cytoplasmic regions of a number of herpesvirus
gB proteins has been shown to increase gB fusogenicity (Browne
et al., 2001; Bzik et al., 1984; Cai et al., 1988; Foster et al., 2001;
Gage et al., 1993; Klupp et al., 2000; Muggeridge, 2000; Pertel,
2002), consistent with the possibility that the C-terminal residues
could influence the stability of a prefusion conformation.
The observations of proteolytic cleavage at the EBV gB furin
site, the effects of the C-terminus on the proteolytic processing
in longer ectodomain variants and the ability of gB to form
rosettes through hydrophobic loops are novel features that relate
gB to other well-characterized class I and II fusion proteins.
Together these data reinforce the hypothesis that herpesvirus gB
plays a central role in viral and cellular membrane merger.
Materials and methods
Cloning of gB ectodomains into pBACgus-3 vector
Two variants of the EBV gB ectodomain, EctoS and EctoL,
strain B95-8, were obtained by PCR amplification using a
plasmid containing full-length gB (Haan et al., 2001). Briefly,
gB-specific primers, which contained restriction sites unique for
the baculovirus transfer plasmid pBACgus-3 (Novagen), were
designed and used for PCR. The DNA encoding the ectodomain
fragments and pBACgus-3 vector were then digested with the
restriction enzymes and ligated (Fast-Link ligation kit, Epicen-
tre) to produce the EctoS and EctoL constructs.
The EctoS variant (residues 23–683 of immature gB) lacked
the 22-residue long gB signal sequence, and was cloned
between NcoI and NheI restriction sites in pBACgus-3. The
resulting DNA construct had the vector-encoded gp64 signal
sequence (that drives protein secretion), the short gB ectodo-
main and a C-terminal histidine tag.
The EctoL variant also contains the gp64 signal sequence
and was designed to have a GCN4 trimerization domain at the
C-terminus of a gB ectodomain. The appended GCN4 sequence
is the isoleucine-containing mutant of the GCN4 dimerization
domain, and the mutated sequence has been previously shown
to form a trimer (Harbury et al., 1994). This construct was
produced by cloning the longer gB ectodomain (residues
23–733 of immature protein) into pBACgus-3 vector that
contained a GCN4 sequence introduced immediately down-
stream of the AvrII site in pBACgus-3. The trimerization
sequence was inserted by an adaptation of the QuickChange(Stratagene) site-directed mutagenesis method. The GCN4 was
first amplified by PCR using a template plasmid simian virus 5
F-GCNt (Yin et al., 2006) and primers that were designed to
anneal both to the GCN4 (underlined) and pBACgus-3 vector
(italic) sequences: forward primer 5′ CAC CAC CAC CAC CAC
TAA CCTAGGGAAGACAAAATCGAAGAAATCCTG 3′,
and reverse primer 5′ ATC AAA AAA CTG ATC GGT GAA
GCA TAA CGC ATG CAA GCT GAT CCG GGT TAT 3′. The
GCN4 amplification product was added instead of mutagenesis
primers in the QuickChange mutagenesis step subsequently
done on pBACgus-3 vector as described (Geiser et al., 2001;
Makarova et al., 2000). The DNA encoding the gB ectodomain
was then cloned into the modified pBACgus-3 vector between
NcoI and AvrII sites, and a vector-encoded stop codon, located
between the AvrII site and GCN4 sequence, was deleted by
another cycle of QuickChange site-directed mutagenesis
according to the manufacturer's instructions. The resulting
construct encoded the cleavable gp64 signal peptide, long gB
ectodomain and GCN4 trimerization sequence appended at the
C-terminus.
The EctoL/EK variant was created by QuickChange site-
directed mutagenesis, using the EctoL construct as template,
and a pair of complementary primers encoding the enterokinase
recognition site. Sequence of the forward mutagenesis primer
was 5′ GCC GCC GTT CTG GAT GAT GAT GATAAA GAT
GCG GGG AAC 3′.
The EctoS/FL variant had wild type residues WY112–113 and
WLIW193–196 changed to, respectively, HR and RVEA.
Mutations were introduced into a gB pSG5 vector (Stratagene)
using a PCR overlap extension method (Horton et al., 1993),
and following mutagenesis primers: 5′-CGC CCC CGG GCG
TGT GGA GGC TAC TTA CAG AAC-3′ for RVEA193–196 and
5′-ATC TACAATGGC CACAGAGCGGAC TCCGTGA-3′
for HR112–113 (Backovic et al., 2007). The DNA fragment
containing the mutations was amplified using primers contain-
ing NcoI and PstI restriction sites. The DNA amplification
product and an EctoS construct were then digested with NcoI
and PstI enzymes, and ligated with FastLink DNA ligase
(Epicentre). The EctoS construct used for creation of the EctoS/
FL variant was produced by cloning gB between NcoI at 5′ and
AvrII at 3′ restriction sites in pBACgus-3 vector, and unlike the
EctoS construct described in this study, it did not contain
histidine tag.
All clones were sequenced to verify the reading frame and
the appropriate sequences were obtained in the final constructs.
Expression, isolation and purification of gB ectodomains
Baculogold Bright Baculovirus DNA (BD Biosciences) and
the pBACgus-3 constructs described above were used for
production of recombinant baculovirus in Sf9 cells (Invitrogen).
Recombinant viruses were subjected to two cycles of am-
plification in Sf9 cells cultured in monolayers in TNM-FH
media (BD Biosciences). Each amplification round was 7–10
days long. High Five insect cells (BTI-TN-5B1-4, Invitrogen)
were grown in suspension in Excell-405 media (JRH Bios-
ciences) to 2×106 cells/ml and were infected with viral stocks.
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amount of expressed protein. Typically 12–15 ml of a stock was
used for infection of 0.6–0.7×106 High Five cells. Media
containing recombinant ectodomains were harvested 48–56 h
post-infection and cell debris was removed by centrifugation.
The supernatants were made to contain 0.1 mM PMSF and
0.02% sodium azide, and the solutions were stored at 4 °C.
The gB ectodomains were purified by immunoaffinity
chromatography using monoclonal antibody CL55 which rec-
ognizes gB. CL55 antibody was produced from the hybridoma,
provided kindly by L. Hutt-Fletcher, in the Northwestern
Monoclonal Antibody Facility and purified using protein G
affinity resin. Fifteen milligrams of antibody was coupled to
UltraLink Hydrazide resin (Pierce) with 60% efficiency,
according to the procedure supplied by the manufacturer. Two
milliliters of the resin was poured into a glass column, and
supernatants were loaded onto the matrix by gravity flow. After
washing with 40 ml of PBS, elution was done by running 2 ml
of 0.2 M glycine pH 2.5, five times over the column to ensure
the complete dissociation of gB from CL55 antibody. The
majority of gB came off the column in the first and second
elution fractions. The eluate was dripped into 2 ml of 1 M Tris
buffer pH 9 in order to raise the pH of the eluted material to pH
7.0. Proteins were immediately dialyzed into 50 mM Tris,
50 mM NaCl pH 8.
Size exclusion chromatography
Proteins purified on the CL55 immunoaffinity matrix were
dialyzed with 50 mM Tris, 50 mM NaCl pH 8 and concentrated
using an Amicon Ultra-15 concentrator (Millipore) with 50 kDa
molecular mass cutoff. Concentrated proteins were then loaded
on a Superdex 200 (S200) gel filtration column (Amersham
Pharmacia), connected to an AKTA Explorer purification
system to carry out the size exclusion chromatography
experiments. Protein absorbance was monitored at 280 nm,
and 0.5 or 0.6 ml fractions were collected at 0.5 or 0.6 ml/min
flow rate.
A stock solution of sodium deoxycholate (DOC) (0.25M)was
made in 50 mMTris, 50 mMNaCl pH 8.2 buffer, and appropriate
volumes were added to the protein sample or running buffer to
30 mM final concentration. The running buffer used for EctoS,
EctoL and Ecto/EK was 50 mM Tris, 50 mM NaCl pH 8 (or pH
8.2 if DOC was present). The running buffer used for EctoS/FL
variant was 10 mM Tris, 100 mM NaCl pH 7.4.
Sucrose density gradient centrifugation
Sucrose gradients consisted of 1 ml of 60% sucrose, 1 ml of
40% sucrose, 1 ml of 20% sucrose and 1 ml of 10% sucrose.
0.2 ml of concentrated supernatant or immunoaffinity purified
gB was overlaid on top of the sucrose gradient and was
subjected to centrifugation in SW60 rotor at 30,000 rpm for 18 h
at 20 °C. After centrifugation, 0.6 ml fractions were recovered
and 25 μl of each fraction was analyzed for presence of gB by
SDS-PAGE and Western blotting. A rabbit polyclonal antibody
that recognizes EBV gB and secondary antibody conjugated toalkaline phosphatase were used for the Western blotting
(described below).
Electrophoresis and Western blotting
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) was done on 6–10% acrylamide resolving gels
(Laemmli, 1970), depending on the molecular masses of protein
species being separated. Gels were run for 1–1.5 h at 100 V. To
visualize polypeptides, gels were stained with Commassie
brilliant blue dye for 1 h and washed multiple times in
methanol-acetic acid destain solution.
For immunoblotting (Burnette, 1981), proteins were trans-
ferred onto polyvinylidene fluoride Immobilon-P membrane
(Millipore) for 45 min at 70 V. Membranes were blocked for 1 h
at room temperature in TBST buffer (25 mM Tris, 250 mM
NaCl pH 7.4, 0.1% Tween 20 containing 5% non-fat milk). The
rabbit polyclonal antibody recognizing EBV gB was made by
DNA immunization of rabbits with EBV gB expression vectors
(Aldevron, North Dakota). Incubations with primary antibodies
(1:1000), dilution for monoclonal anti-histidine immunoglobu-
lin (Ig G1) antibody (Novagen) or 1:500 dilution for the rabbit
polyclonal anti-gB was done over night at 4 °C in TBST, 5%
non-fat milk. This was followed by 2 h incubation with a
secondary antibody conjugated to alkaline phosphatase (AP) at
room temperature, and development using an AP conjugate
substrate kit (BioRad). Dilutions of secondary antibodies used
were 1:2500 both for the AP-conjugated goat anti-mouse IgG
(Sigma) and goat anti-rabbit IgG (Kierkegaard and Perry
Laboratories).
Transmission electron microscopy
Protein samples were adsorbed onto glow-discharged copper
carbon-coated grids (Electron Microscope Sciences), and
stained with 2% sodium phosphotungstate. Electron micro-
scopy was performed using a JOEL 1230 transmission electron
microscope operated at 100 kV, as described previously
(Wrigley et al., 1983).
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